Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to NBC10 about Leqembi, which has been granted full approval by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease. The drug is indicated for those with mild cognitive impairment or the mild dementia stage of Alzheimer’s.
IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH